PTTG3P and hepatocellular carcinoma: Among the 5 potential oncogenic lncRNAs, both PTTG3P and RACGA1P were previously reported to be pseudogenes that were overexpressed in HCC and were also shown to enhance cell cycle progression and activate Rho-GTPase signaling pathways respectively36–38.